Showing BioInteractions for Minocycline (DB01017)
BioInteractor utilizes data on drug-target, -enzyme and -transporter associations to provide insight on drug-drug interactions. It allows you to identify, for instance, which drugs act similarly on the same target. Such drugs may have additive pharmacodynamic effects if given concomitantly. Conversely, two drugs may antagonize the beneficial effects of each other by having opposite actions on a specific drug target. BioInteractor uses ranked drug-enzyme association information to predict enzyme-mediated drug interactions that may be clinically relevant.
Interacting Group | Interacting Drugs | |
---|---|---|
Minocycline is a 30S ribosomal protein S4 inhibitor | ||
1 | 30S ribosomal protein S4 inhibitors | Clomocycline, Eravacycline, Lymecycline, Oxytetracycline |
Interacting Group | Interacting Drugs | |
---|---|---|
Minocycline is a 30S ribosomal protein S9 inhibitor | ||
1 | 30S ribosomal protein S9 inhibitors | Clomocycline, Oxytetracycline, Rolitetracycline |
Interacting Group | Interacting Drugs | |
---|---|---|
Minocycline is a 16S ribosomal RNA inhibitor | ||
1 | 16S ribosomal RNA inhibitors | Chlortetracycline, Clomocycline, Framycetin, Kanamycin, Metacycline, Neomycin, Netilmicin, Omadacycline, Oxytetracycline, Paromomycin, Rolitetracycline, Streptomycin, Tetracycline, Tobramycin |
2 | 16S ribosomal RNA binders | Doxycycline |
Interacting Group | Interacting Drugs | |
---|---|---|
Minocycline is a Interleukin-1 beta modulator | ||
1 | Interleukin-1 beta binders | Canakinumab, Rilonacept |
2 | Interleukin-1 beta antagonists | Gallium nitrate |
3 | Interleukin-1 beta agonists | Foreskin keratinocyte (neonatal) |
4 | Interleukin-1 beta inhibitors | Donepezil |
5 | Interleukin-1 beta inducers | Donepezil |
Interacting Group | Interacting Drugs | |
---|---|---|
Minocycline is a Arachidonate 5-lipoxygenase inhibitor | ||
1 | Arachidonate 5-lipoxygenase inhibitors | Aminosalicylic acid, Balsalazide, Cannabidiol, Diacerein, Diethylcarbamazine, Fostamatinib, Hyperforin, Masoprocol, Meclofenamic acid, Medical Cannabis, Mesalazine, Morniflumate, Nabiximols, Rhein, Sulfasalazine, Zileuton |
2 | Arachidonate 5-lipoxygenase substrates | Omega-3 fatty acids, Omega-6 fatty acids |
3 | Arachidonate 5-lipoxygenase antagonists | Morniflumate |
4 | Arachidonate 5-lipoxygenase potentiators | Diclofenac |
Interacting Group | Interacting Drugs | |
---|---|---|
Minocycline is a Matrix metalloproteinase-9 inhibitor | ||
1 | Matrix metalloproteinase-9 inhibitors | Captopril, Marimastat |
2 | Matrix metalloproteinase-9 antagonists | Glucosamine |
3 | Matrix metalloproteinase-9 binders | Zinc chloride, Zinc sulfate, unspecified form |
Interacting Group | Interacting Drugs | |
---|---|---|
Minocycline is a Vascular endothelial growth factor A inhibitor | ||
1 | Vascular endothelial growth factor A inhibitors | Brolucizumab, Dalteparin, Vandetanib |
2 | Vascular endothelial growth factor A antagonists | Faricimab, Pegaptanib |
3 | Vascular endothelial growth factor A binders | Aflibercept |
4 | Vascular endothelial growth factor A agonists | Foreskin keratinocyte (neonatal) |
Interacting Group | Interacting Drugs | |
---|---|---|
Minocycline is a Caspase-1 negative modulator | ||
1 | Caspase-1 inhibitors | Acetylsalicylic acid |
Interacting Group | Interacting Drugs | |
---|---|---|
Minocycline is a Caspase-3 negative modulator | ||
1 | Caspase-3 antagonists | Glycyrrhizic acid |
2 | Caspase-3 inhibitors | Acetylsalicylic acid |
3 | Caspase-3 activators | Incadronic acid |
Interacting Group | Interacting Drugs | |
---|---|---|
Minocycline is a Cytochrome c negative modulator | ||
1 | Cytochrome c ligands | Artenimol |
Interacting Group | Interacting Drugs | |
---|---|---|
Minocycline is a Mitogen-activated Protein Kinases inhibitor |
Interacting Group | Interacting Drugs | |
---|---|---|
Minocycline is a Nitric oxide synthase, inducible inhibitor | ||
1 | Nitric oxide synthase, inducible negative modulators | Dexamethasone, Dexamethasone acetate |
2 | Nitric oxide synthase, inducible inhibitors | Miconazole, Pimagedine |
3 | Nitric oxide synthase, inducible agonists | Levamlodipine, Triflusal |
4 | Nitric oxide synthase, inducible substrates | Doxorubicin |
5 | Nitric oxide synthase, inducible inducers | Levamlodipine |
6 | Nitric oxide synthase, inducible antagonists | Dipyrithione |
Interacting Group | Interacting Drugs | |
---|---|---|
Minocycline is a Solute carrier family 22 member 7 inhibitor | ||
1 | Solute carrier family 22 member 7 inhibitors | Bumetanide, Cefalotin, Cefamandole, Cefoperazone, Cefotaxime, Cholic Acid, Cimetidine, Clarithromycin, Dinoprostone, Enalapril, Ganciclovir, Glyburide, Ketoprofen, Oxtriphylline, Oxytetracycline, Probenecid, Rifampicin, Testosterone, Tetracycline, Theophylline |
2 | Solute carrier family 22 member 7 substrates | Allopurinol, Aminohippuric acid, Cimetidine, Cyclic adenosine monophosphate, Dinoprostone, Docetaxel, Fluorouracil, Glutaric Acid, Indomethacin, Methotrexate, Oxytetracycline, Pravastatin, Salicylic acid, Tegafur-uracil, Valproic acid, Zalcitabine |
3 | Solute carrier family 22 member 7 inducers | Testosterone cypionate, Testosterone enanthate, Testosterone undecanoate |
Interacting Group | Interacting Drugs | |
---|---|---|
Minocycline is a Outer membrane protein F substrate | ||
1 | Outer membrane protein F substrates | Meclocycline |
Interacting Group | Interacting Drugs | |
---|---|---|
Minocycline is a Outer membrane porin C substrate |